Tuesday, September 19, 2017 1:10:02 PM
Not likely there will be any funding before 2018 and if there is that is no guarantee that will translate into increased revenues. The CEO's picking of partners in the past hasn't worked out so well and sales are tanking year after year.
Stock is being constantly diluted which will only lead into another RS in the near future. Once the first hint of an RS comes from the company the stock will drop to No Bid with no chance of selling.
Remember that when someone tries to convince you to sell there is something in it for them. It's not because they are concerned about your investment.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM